Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Khasraw

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Scientific Reports|March 1, 2019
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)Wendy Ha, Hatice Sevim-Nalkiran, Ashraf M Zaman, et al.
Molecular Cancer Therapeutics|January 6, 2021
Salting the Soil: Targeting the Microenvironment of Brain MetastasesEthan S Srinivasan, Aaron C Tan, Carey K Anders, et al.
Trends in Cancer|November 14, 2025
The promise of TIL therapy for glioblastomaEmma L Pristo, Kelly M Hotchkiss, Anna M Corcoran, et al.
Oncotarget|March 1, 2018
The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selectionAndrea M Muscat, Nicholas C Wong, Katharine J Drummond, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyGeorgia Harris, Dasantha Jayamanne, Helen Wheeler, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 31, 2023
Novel Immunotherapeutic Approaches for the Treatment of GlioblastomaSaïf Eddine Zaidi, Eliese Moelker, Kirit Singh, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Frontiers in Oncology|July 5, 2021
Targeting Immunometabolism in GlioblastomaAditya A Mohan, William H Tomaszewski, Aden P Haskell-Mendoza, et al.
Neuro-Oncology Practice|November 17, 2022
Patterns of care in adult histone mutant gliomas: Results of an international surveyAlexander Yuile, Mustafa Khasraw, Justin T Low, et al.
Neuro-Oncology|May 22, 2026
Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step?Mustafa Khasraw, Matthew D Dun, Isabel Arrillaga-Romany, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Scientific Reports|March 1, 2019
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)Wendy Ha, Hatice Sevim-Nalkiran, Ashraf M Zaman, et al.
Molecular Cancer Therapeutics|January 6, 2021
Salting the Soil: Targeting the Microenvironment of Brain MetastasesEthan S Srinivasan, Aaron C Tan, Carey K Anders, et al.
Trends in Cancer|November 14, 2025
The promise of TIL therapy for glioblastomaEmma L Pristo, Kelly M Hotchkiss, Anna M Corcoran, et al.
Oncotarget|March 1, 2018
The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selectionAndrea M Muscat, Nicholas C Wong, Katharine J Drummond, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyGeorgia Harris, Dasantha Jayamanne, Helen Wheeler, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 31, 2023
Novel Immunotherapeutic Approaches for the Treatment of GlioblastomaSaïf Eddine Zaidi, Eliese Moelker, Kirit Singh, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Frontiers in Oncology|July 5, 2021
Targeting Immunometabolism in GlioblastomaAditya A Mohan, William H Tomaszewski, Aden P Haskell-Mendoza, et al.
Neuro-Oncology Practice|November 17, 2022
Patterns of care in adult histone mutant gliomas: Results of an international surveyAlexander Yuile, Mustafa Khasraw, Justin T Low, et al.
Neuro-Oncology|May 22, 2026
Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step?Mustafa Khasraw, Matthew D Dun, Isabel Arrillaga-Romany, et al.
Pageof 18